# Use of NPSP558 in the Treatment of Hypoparathyroidism

> **NCT00732615** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 124 (actual)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **DRUG:** Placebo
- **DRUG:** NPSP558

## Key facts

- **NCT ID:** NCT00732615
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-18
- **Primary completion:** 2011-09-28
- **Final completion:** 2011-09-28
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2021-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00732615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00732615, "Use of NPSP558 in the Treatment of Hypoparathyroidism". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00732615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*